No oral anticoagulation

OTHER3 trials

Sponsors

University Hospital, Strasbourg, France, Unity Health Toronto

Conditions

Atrial FibrillationAtrial FlutterDialysis PatientsEnd Stage Kidney Disease (ESRD)End Stage Renal Failure on DialysisKidney Failure, Chronic

Phase 2

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

CompletedNCT03987711

Unity Health TorontoAtrial Fibrillation, End Stage Renal Failure on Dialysis

Start: 2019-12-10End: 2022-12-31Updated: 2023-06-22

Phase 3

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)

Not yet recruitingNCT07779746

Unity Health TorontoAtrial Fibrillation, Atrial Flutter, Dialysis Patients +1

Start: 2026-11-01End: 2032-11-01Target: 848Updated: 2026-08-21

Phase 4

Oral Anticoagulation in Haemodialysis Patients

TerminatedNCT02886962

University Hospital, Strasbourg, FranceKidney Failure, Chronic

Start: 2017-07-12End: 2023-12-01Updated: 2024-08-20

Related Papers

Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

Journal of the American Society of Nephrology2024-11-049 citations

Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: PRO

Kidney3602021-04-093 citations

Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: CON

Kidney3602021-04-092 citations